Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Effectiveness of Hepatitis B Virus Vaccination Program in Egypt: Seroprotection and HBV infection

Domaine:

healthcare
Créateur:
Sai
Éditeur:
unp
Hôte:avatar

Visit

doi.orgwww.researchgate.net

Similaires

Effect of Hepatitis B Virus (HBV) Infection on Lipid Profile in Ghanaian PatientsHepatitis B Virus (HBV) Risk Assessment — GhanaCirculation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV/HBV co-infected patients in Korle-Bu, GhanaModelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South AfricaA study of knowledge, experience and beliefs about hepatitis B virus (HBV) infection in south western UgandaScreening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Effect of Hepatitis B Virus (HBV) Infection on Lipid Profile in Ghanaian Patients

Background: Worldwide, approximately 257 million people have chronic hepatitis B virus (HBV) infec

Hepatitis B Virus (HBV) Risk Assessment — Ghana

A comprehensive R-based analysis pipeline and additional files for the manuscript "A CROSS-SECTIONAL

Circulation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV/HBV co-infected patients in Korle-Bu, Ghana

Background Within HIV/HBV infected patients, an increase in HDV infection has been observed; there

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa

Background: International sustainable development goals for the elimination of viral hepatitis a

A study of knowledge, experience and beliefs about hepatitis B virus (HBV) infection in south western Uganda

ABSTRACT Introduction United Nations susta

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Background
In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving